Valuation: Terumo Corporation

Market Cap 3,53900Cr 2.26TCr 2.02TCr 1.86TCr 1.69TCr 3.16TCr 2,14200Cr 3.21TCr 22TCr 8.87TCr 1,12200Cr 8.47TCr 8.29TCr P/E 2027 *
29.2x
P/E 2028 * 18.5x
Enterprise Value 3,60400Cr 2.3TCr 2.05TCr 1.9TCr 1.72TCr 3.21TCr 2,18200Cr 3.27TCr 23TCr 9.03TCr 1,14300Cr 8.63TCr 8.44TCr EV / Sales 2027 *
2.87x
EV / Sales 2028 * 2.66x
Free-Float
97.34%
Yield 2027 *
1.43%
Yield 2028 * 1.64%

Last Transcript: Terumo Corporation

1 day-1.26%
1 week+4.19%
Current month+4.44%
1 month+7.19%
3 months+9.10%
6 months+13.56%
Current year+5.68%
1 week 2,326.5
Extreme 2326.5
2,506
1 month 2,215.5
Extreme 2215.5
2,506
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,900
Extreme 1900
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.26%+4.19%-7.78%+24.01% 2.28TCr
+1.16%-1.13%-17.92%+8.27% 18TCr
-1.22%+0.70%+1.27%+31.80% 12TCr
+0.02%+4.24%-19.82%+16.53% 12TCr
+2.29%+21.86%-41.81%+11.12% 9.12TCr
-2.21%-2.91%+0.74%+75.30% 6.46TCr
-1.06%+4.59%+13.36%+78.58% 5.61TCr
-0.75%+3.73%+6.64%-22.28% 5.46TCr
-1.13%+0.00%-12.25%+31.02% 4.36TCr
+0.17%+5.12%-4.89%-10.48% 3.4TCr
Average -0.41%+4.35%-8.25%+24.39% 7.8TCr
Weighted average by Cap. -0.09%+3.61%-11.40%+22.80%

Financials

2027 *2028 *
Net sales 1,25500Cr 800.33Cr 714.69Cr 660.24Cr 598.32Cr 1.12TCr 76TCr 1.14TCr 7.95TCr 3.15TCr 40TCr 3TCr 2.94TCr 1,32400Cr 844.56Cr 754.19Cr 696.73Cr 631.39Cr 1.18TCr 80TCr 1.2TCr 8.38TCr 3.32TCr 42TCr 3.17TCr 3.1TCr
Net income 12TCr 77Cr 69Cr 64Cr 58Cr 108.33Cr 7.35TCr 110.13Cr 768.93Cr 304.42Cr 3.85TCr 290.68Cr 284.5Cr 19TCr 121.56Cr 108.55Cr 100.28Cr 91Cr 170.02Cr 12TCr 172.84Cr 1.21TCr 477.77Cr 6.05TCr 456.21Cr 446.51Cr
Net Debt 6.51TCr 41Cr 37Cr 34Cr 31Cr 58Cr 3.94TCr 59Cr 411.9Cr 163.07Cr 2.06TCr 155.71Cr 152.4Cr -1.68TCr -11Cr -9.59Cr -8.86Cr -8.03Cr -15Cr -1.02TCr -15Cr -106.58Cr -42Cr -533.97Cr -40Cr -39Cr
Projected Income Statement - Annual - Terumo Corporation
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
23/26/23 JP¥2,399.00 -1.26% 84,97,500
22/26/22 JP¥2,429.50 +1.02% 56,97,700
21/26/21 JP¥2,405.00 -0.06% 62,82,300
20/26/20 JP¥2,406.50 +2.84% 59,45,300
19/26/19 JP¥2,340.00 +0.13% 53,77,900
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Terumo Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,399.00JPY
Average target price
3,012.31JPY
Spread / Average Target
+25.57%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Terumo Corporation
  1. Stock Market
  2. Stocks
  3. 4543 Stock